找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Radiopharmaceutical Therapy; Lisa Bodei,Jason S. Lewis,Brian M. Zeglis Book 2023 The Editor(s) (if applicable) and The Author(s), under ex

[復(fù)制鏈接]
查看: 46888|回復(fù): 61
樓主
發(fā)表于 2025-3-21 16:15:02 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱(chēng)Radiopharmaceutical Therapy
編輯Lisa Bodei,Jason S. Lewis,Brian M. Zeglis
視頻videohttp://file.papertrans.cn/821/820888/820888.mp4
概述First book of its kind of to cover radiopharmaceutical therapy.Comprehensive and accessible introduction to a rapidly-growing field.Useful for a broad audience of scientists, researchers, physicians,
圖書(shū)封面Titlebook: Radiopharmaceutical Therapy;  Lisa Bodei,Jason S. Lewis,Brian M. Zeglis Book 2023 The Editor(s) (if applicable) and The Author(s), under ex
描述.This book covers foundational topics in the emerging field of radiopharmaceutical therapy. It?is divided into three sections: fundamentals, deeper dives, and special topics. In the first section, the authors examine the field from a bird’s-eye view, covering topics including the history of radiopharmaceutical therapy, the radiobiology of radiopharmaceutical therapy, and the radiopharmaceutical chemistry of both metallic and non-metallic radionuclides. The second section provides a more in-depth look at specific radiotherapeutics. Chapters include broader discussions of the different platforms for radiopharmaceutical therapy as well as more focused case studies covering individual radiotherapeutics. The third and final section explores a number of areas for further study, including medical physics, artificial intelligence,?.in vivo?.pretargeting, theranostic imaging, and the regulatory review process for radiotherapeutics..This book is the first of its kind andis useful for a broad audience of scientists, researchers, physicians, and students across a range of fields, including biochemistry, cancer biology, nuclear medicine, radiology, and radiation oncology..
出版日期Book 2023
關(guān)鍵詞radiotherapy; cancer therapy; endoradiotherapy; radiopharmaceutical chemistry; Radiotherapeutics; Radioim
版次1
doihttps://doi.org/10.1007/978-3-031-39005-0
isbn_softcover978-3-031-39772-1
isbn_ebook978-3-031-39005-0
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

書(shū)目名稱(chēng)Radiopharmaceutical Therapy影響因子(影響力)




書(shū)目名稱(chēng)Radiopharmaceutical Therapy影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Radiopharmaceutical Therapy網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Radiopharmaceutical Therapy網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Radiopharmaceutical Therapy被引頻次




書(shū)目名稱(chēng)Radiopharmaceutical Therapy被引頻次學(xué)科排名




書(shū)目名稱(chēng)Radiopharmaceutical Therapy年度引用




書(shū)目名稱(chēng)Radiopharmaceutical Therapy年度引用學(xué)科排名




書(shū)目名稱(chēng)Radiopharmaceutical Therapy讀者反饋




書(shū)目名稱(chēng)Radiopharmaceutical Therapy讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶(hù)組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:31:39 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:50:12 | 只看該作者
978-3-031-39772-1The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
地板
發(fā)表于 2025-3-22 04:52:31 | 只看該作者
Lisa Bodei,Jason S. Lewis,Brian M. ZeglisFirst book of its kind of to cover radiopharmaceutical therapy.Comprehensive and accessible introduction to a rapidly-growing field.Useful for a broad audience of scientists, researchers, physicians,
5#
發(fā)表于 2025-3-22 09:07:33 | 只看該作者
The Production of Therapeutic Radionuclidesh the decay of long-lived radionuclides such as .U, .Th, and .U, upon which chemically distinct daughters can be separated for incorporation into radiopharmaceuticals. The rate of the production of a given radionuclide depends on the cross section of the nuclear reaction on the target material, the
6#
發(fā)表于 2025-3-22 13:41:48 | 只看該作者
7#
發(fā)表于 2025-3-22 17:46:55 | 只看該作者
8#
發(fā)表于 2025-3-23 00:06:59 | 只看該作者
9#
發(fā)表于 2025-3-23 05:23:38 | 只看該作者
Case Study #3: Antibody Fragments in Radiopharmaceutical Therapylity, unfavorable tissue distribution, and reduced binding affinity of radiolabeled antibody fragments have inhibited their widespread application in radiopharmaceutical therapy. In response, a great deal of effort has been dedicated to optimize the pharmacokinetics of antibody fragments (especially
10#
發(fā)表于 2025-3-23 06:38:13 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-18 05:02
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
德州市| 惠安县| 阿拉善右旗| 海阳市| 祁阳县| 浏阳市| 个旧市| 昆山市| 如皋市| 凤翔县| 正定县| 绿春县| 利辛县| 大同县| 古丈县| 赞皇县| 和平县| 绥芬河市| 达日县| 柞水县| 象山县| 凤山县| 宁城县| 邵阳县| 易门县| 靖州| 阿拉善右旗| 白城市| 广水市| 同仁县| 高邮市| 新密市| 潞西市| 汉沽区| 望奎县| 平阴县| 茂名市| 宝鸡市| 昆明市| 比如县| 大英县|